Libtayo
Drug timelines are a Plus or Pro feature.
53 regulatory and trial events tracked for Libtayo, covering 2018-09-28 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer [Phase 3]